A particular region of the CpG island encompassing CASR gene promoter 2 was found to be hypermethylated in 25% primary neuroblastomas, in association with reduced CaSR mRNA expression, MYCN amplification, undifferentiated histopathology and other factors of poor outcome. The gene discussed is CASR; the disease is neuroblastoma.